Komori
Medical Ikkou Group (3353) · RiskMitigated

Price fluctuation risk of investment securities

First written in FY2018. 7 of 27 entries say "Worsened", first in FY2023. Latest entry: FY2027-H1.

27entries
9years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018 – FY2022-Q22018: 120182019: 220192020: 320202021: 420212022: 320222023: 320232024: 320242025: 220252026: 62026
Same theme, other companies
Valuation Losses Due to Declines in the Market Value of Securities HeldA theme 228 companies write about · 225 as a headwind · 3 as a tailwind

The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.

53 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 230 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1MitigatedAnnual report

    「Total property, plant and equipment was ¥17,224 million, a decrease of ¥1,204 million from the end of the previous consolidated fiscal year. This was mainly attributable to decreases of ¥209 million in buildings and structures, net, ¥426 million in investment securities, and ¥581 million in other investments and other assets, despite an increase of ¥40 million in land.」

    Investment securities decreased by ¥426 million from the end of the previous consolidated fiscal year, reducing exposure to price volatility risk.
  2. FY2026WorsenedAnnual report

    「As of the end of February 2026, the Group held investment securities of ¥3,398.068 million.」

    The balance of investment securities increased from ¥2,405.444 million at the end of the previous fiscal year to ¥3,398.068 million, increasing exposure to price fluctuation risk.
  3. FY2026-H1MitigatedAnnual report

    「Investment securities 2,405,444 2,355,918」

    The balance of investment securities decreased by ¥49.526 million from ¥2,405.444 million at the end of the previous consolidated fiscal year to ¥2,355.918 million, reducing exposure to price fluctuation risk.
  4. FY2025WorsenedAnnual report

    「As of the end of February 2025, the Group held investment securities of ¥2,405.444 million.」

    The balance of investment securities increased from ¥2,097.193 million at the end of the previous fiscal year to ¥2,405.444 million, increasing exposure to price fluctuation risk.
  5. FY2025-H1MitigatedAnnual report

    「Investment securities 2,097,193 2,036,948」

    The balance of investment securities decreased by ¥60.245 million from ¥2,097.193 million at the end of the previous consolidated fiscal year to ¥2,036.948 million, reducing exposure to price fluctuation risk. quantified: true, materialized: false.
  6. FY2025-Q1Slight increase in holdingsAnnual report

    「Investment securities 2,097,193 2,108,341」

    The balance of investment securities increased slightly from ¥2,097.193 million at the end of the previous consolidated fiscal year to ¥2,108.341 million.
  7. FY2024-Q3WorsenedAnnual report

    「This was mainly due to increases of ¥357 million in investment securities and ¥315 million in other investments and other assets, respectively, offset by decreases of ¥227 million in buildings and structures, net, and ¥135 million in goodwill, respectively, among other factors.」

    The balance of investment securities increased by ¥357 million from the end of the previous consolidated fiscal year, increasing exposure to price fluctuation risk.
  8. FY2024-Q2WorsenedAnnual report

    「This was mainly due to increases of ¥255 million in investment securities, ¥141 million in other property, plant and equipment, net, and ¥137 million in other investments and other assets, respectively, offset by decreases of ¥193 million in buildings and structures, net, and ¥97 million in goodwill, respectively, among other factors.」

    The balance of investment securities increased by ¥255 million from the end of the previous consolidated fiscal year, increasing exposure to price fluctuation risk.
  9. FY2024-Q1MitigatedAnnual report

    「This was mainly due to increases of ¥207 million in other investments and other assets, offset by decreases of ¥94 million in buildings and structures, net, and ¥58 million in investment securities, respectively, among other factors.」

    The balance of investment securities decreased by ¥58 million from the end of the previous consolidated fiscal year, reducing exposure to price fluctuation risk.
  10. FY2023WorsenedAnnual report

    「As of the end of February 2023, the Group held investment securities of ¥1,320.428 million.」

    The balance of investment securities increased from ¥1,104.507 million at the end of the previous fiscal year to ¥1,320.428 million, increasing exposure to price fluctuation risk.
  11. FY2023-Q2Slight decrease in holdingsAnnual report

    「Investment securities 1,104,507 1,092,704」

    The balance of investment securities decreased from ¥1,104.507 million at the end of the previous consolidated fiscal year to ¥1,092.704 million.
  12. FY2023-Q1Lower balance-sheet valueAnnual report

    「Investment securities 1,104,507 1,077,303」

    The balance of investment securities decreased from ¥1,104.507 million at the end of the previous consolidated fiscal year to ¥1,077.303 million.
  13. FY2022-Q3MaterialisedAnnual report

    「Loss on valuation of investment securities - 10,000」

    A ¥10 million loss on valuation of investment securities was recognized, indicating that the price fluctuation risk of investment securities had materialized as a valuation loss. The balance of investment securities also decreased by ¥156 million from the end of the previous consolidated fiscal year.
  14. FY2022-Q2Decrease in holdingsAnnual report

    「Total property, plant and equipment and intangible assets was ¥14,501 million, a decrease of ¥398 million from the end of the previous consolidated fiscal year. This was mainly due to an increase of ¥562 million in land, offset by decreases of ¥443 million in other property, plant and equipment, ¥201 million in investment securities, ¥142 million in buildings and structures, net, and ¥124 million in goodwill, respectively, among other factors.」

    Investment securities decreased by ¥201 million from the end of the previous consolidated fiscal year, reducing exposure to price fluctuation risk.
  15. FY2022-Q1Decrease in holdingsAnnual report

    「Total property, plant and equipment and intangible assets was ¥14,876 million, a decrease of ¥24 million from the end of the previous consolidated fiscal year. This was mainly due to an increase of ¥148 million in other property, plant and equipment, offset by decreases of ¥101 million in investment securities and ¥62 million in goodwill, respectively, among other factors.」

    Investment securities decreased by ¥101 million from the end of the previous consolidated fiscal year, reducing exposure to price fluctuation risk.
  16. FY2021Decrease in holdingsAnnual report

    「As of the end of February 2021, the Group held investment securities of ¥1,090.920 million.」

    Holdings of investment securities decreased from ¥1,149.689 million at the end of the previous fiscal year to ¥1,090.920 million.
  17. FY2021-Q3Decrease in holdingsAnnual report

    「Total property, plant and equipment and intangible assets was ¥15,088 million, an increase of ¥1,078 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥658 million in goodwill, ¥228 million in other property, plant and equipment, ¥175 million in other investments and other assets, and ¥167 million in lease and guarantee deposits, respectively, together with a ¥205 million decrease in investment securities, among other factors.」

    Investment securities decreased by ¥205 million from the end of the previous consolidated fiscal year, reducing exposure to price fluctuation risk.
  18. FY2021-Q2Decrease in holdingsAnnual report

    「Total property, plant and equipment and intangible assets was ¥13,692 million, a decrease of ¥317 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥369 million decrease in investment securities, among other factors.」

    The balance of investment securities decreased by ¥369 million from the end of the previous consolidated fiscal year, reducing exposure to price fluctuation risk.
  19. FY2021-Q1Decrease in holdingsAnnual report

    「Total property, plant and equipment and intangible assets was ¥13,774 million, a decrease of ¥235 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥207 million decrease in investment securities, among other factors.」

    The balance of investment securities decreased by ¥207 million from the end of the previous consolidated fiscal year to ¥941.737 million.
  20. FY2020-Q3Increase in holdingsAnnual report

    「Investment securities 1,051,454 1,108,142」

    The balance of investment securities increased from ¥1,051.454 million at the end of the previous consolidated fiscal year to ¥1,108.142 million.
  21. FY2020-Q2Increase in holdingsAnnual report

    「Investment securities 1,051,454 1,083,990」

    The balance of investment securities at the end of the quarter was ¥1,083.990 million, up from ¥1,051.454 million at the end of the previous consolidated fiscal year.
  22. FY2019Decrease in holdingsAnnual report

    「As of the end of February 2019, the Group held investment securities of ¥1,051.454 million.」

    Although holdings of investment securities declined from ¥1,510.106 million in the previous fiscal year to ¥1,051.454 million, the disclosure of price fluctuation risk arising from poor performance at investee companies and deterioration in the market has continued.
  23. FY2018First statedAnnual report

    「As of the end of February 2018, the Group held investment securities of ¥1,510.106 million.」

    Discloses the potential impact on performance if share prices decline due to poor performance at investee companies or deterioration in the securities market, together with investment securities held of ¥1,510.106 million.
Moved together

"Restructuring the Group through M&A and Subsidiary Mergers" moved the same way as this thread, in the same document, in 6 of its 27 moves.

655554★123456
  1. ★This thread
  2. 1Restructuring the Group through M&A and Subsidiary Mergers6×
  3. 2Expanding Business Scale and Enhancing Earnings Power5×
  4. 3Sales Activities of Generic Pharmaceutical Wholesalers and Expansion of Sales Areas through Subsidiarization5×
  5. 4Profit Pressure from Intensifying Price Competition in the Pharmaceutical Wholesale Market5×
  6. 5Impact of Interest-Bearing Debt and Interest Rate Trends on Performance5×
  7. 6Pressure on Dispensing Pharmacy Profitability from Revisions to Dispensing Fees and Drug Prices4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Medical Ikkou Group yet. It last moved in the Earnings of 2026-10-09: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Price fluctuation risk of investment securities | Medical Ikkou Group Co.,Ltd. (3353) | Komori